Debenhams, Unilever and Go-Ahead

“Blue-chips opened timidly as investors continued to consider the upcoming UK general election alongside wider geopolitical issues and the stronger pound weighed on the index....

Thu, 20/04/2017 - 10:16


How to claw back portfolio losses

Most investors are comfortable with the fact their portfolio will go up and down, but a big slump in value is extremely stressful and can...

Thu, 20/04/2017 - 01:00


10 bagger: London Stock Exchange

Thousands of investors put their money in the stock markets each day in hope of backing the next big winner – but one of the...

Thu, 20/04/2017 - 01:00


magazine 20 Apr 2017

Download PDF Page flip version

Being an eagle-eyed investor can help you minimise losses – either by avoiding bad investments or spotting red flag warning signs to get out quick. The new issue of Shares has five easy-to-follow steps that could help you make better investment choices.

The key questions on ETFs

Exchange-traded funds (ETFs) are the most successful passive financial products of recent years but there are some concerns about how these instruments perform and their...

Thu, 20/04/2017 - 01:00


Inflation-busting investment trusts

UK inflation is at its highest level since October 2013, putting a squeeze on consumers’ wallets. The latest rate of 2.3% is above the...

Thu, 20/04/2017 - 01:00


The eagle-eyed investor: how to make better investment choices

If an investment loses half of its value you need it to go back up by 100% just to get hit break-even. This bit of...

Thu, 20/04/2017 - 01:00


Focus on Tullow’s balance sheet

Wednesday 26 April

Oil producer Tullow Oil (TLW) is set to update on trading on 26 April, representing for the first...

Thu, 20/04/2017 - 01:00


Our picks are beating the market

Shares’ ‘Top Ten for 2017’ portfolio has made a positive start to 2017. Our average gain of 11.1% is comfortably ahead of the FTSE All-Share’s...

Thu, 20/04/2017 - 01:00


Will AstraZeneca's headache continue?

Thursday 27 April

Investors are already forewarned of a tough 2017 for pharmaceutical business  AstraZeneca (AZN) after guidance in February for...

Thu, 20/04/2017 - 01:00


Pages